- #International medical conferences 2016 registration
- #International medical conferences 2016 professional
![international medical conferences 2016 international medical conferences 2016](https://s33007.pcdn.co/wp-content/uploads/2018/09/health-care_digital_AdobeStock_129476758.jpg)
#International medical conferences 2016 professional
In order to follow up on the most recent advances in the use of medical imaging in the management of CVDs and to support professional development for the purpose of strengthening the capacities of Member States, it is proposed to hold IMIC 2016. Two hundred and forty participants from all over the world, including from 70 Member States and 12 invited organizations, benefited from this conference.
![international medical conferences 2016 international medical conferences 2016](https://chhs.gatech.edu/sites/default/files/news-story-image/3._small_audience_shot_42.jpg)
It was held at the IAEA's Headquarters in Vienna, Austria, and was extremely well received by Member States. IMIC 2013 was organized to improve the understanding of nuclear medicine imaging in the management of CVDs. These approaches include training courses, fellowships, expert missions and conferences, to name a few. The IAEA has been applying many approaches for capacity building in Member States to allow them to optimally utilize medical imaging technologies. Many Member States are already actively using, have recently implemented or are planning to acquire the relevant medical imaging techniques.Ĭapacity building is at the core of IAEA activities, with the ultimate goal in the area of human health being to strengthen the human and technical expertise of Member States to address health challenges in a sustainable and self-resilient manner. Given their high usefulness, integrating these techniques into the health care systems of Member States can provide an invaluable contribution to improving CVD management. Each imaging modality has its advantages and limitations which need to be understood properly by health care professionals dealing with CVDs. These techniques represent very useful tools to understand the pathology of individual patients in detail and can therefore serve to facilitate specifically tailored clinical management. Medical imaging includes techniques such as single photon emission computed tomography (SPECT), positron emission tomography (PET), echocardiography, computed tomography (CT) and magnetic resonance imaging (MRI). It provides invaluable inputs for different stages of CVD management, including diagnosis, staging, treatment, prognosis and follow-up. Medical imaging, including molecular nuclear medicine, is extremely important in that it offers strategic advantages in both diagnostic and therapeutic decision-making. The situation is particularly alarming in low and middle income countries, as 80% of the mortality burden is borne by such countries. Identifying appropriate management strategies is of the utmost importance, as it was estimated by the World Health Organization (WHO) that more than 23 million people will die annually due to CVDs by 2030.
![international medical conferences 2016 international medical conferences 2016](https://www.mrna-conference.com/inhalt/uploads/2019/03/4th_International_mRNA_Health_Conference_in_2016_3.jpg)
Consequently, CVDs are one of the main priorities in the health care systems of many IAEA Member States. Cardiovascular diseases (CVDs) are an important subgroup of NCDs and account for the highest proportional mortality among all NCDs. Non-communicable diseases (NCDs) are steadily increasing both in developed and developing countries. In 2016, the International Atomic Energy Agency (IAEA) will hold the International Conference on Integrated Medical Imaging in Cardiovascular Diseases (IMIC 2016), building on the success of the IMIC 2013 conference. View Poster Flyer Announcement and Call for Papers
#International medical conferences 2016 registration
Online registration has closed however participation is still possible by sending your completed Participation Form (Form A) through the competent official authority (Ministry of Foreign Affairs or National Atomic Energy Authority) to the IAEA.